ALXP
ALSPW
Market cap3mUSD
Oct 28, Last price
0.09EUR
1D
-1.33%
1Q
-34.07%
Jan 2017
-100.00%
IPO
-100.00%
Name
Spineway SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.
Key people
Stephane Le Roux
Chairman of the Board, Chief Executive Officer
Philippe Laurito
Deputy Chief Executive Officer
David Siegrist
Head of Finance
Frederique Girard-Ory
Member of the Executive Board
Michel Onimus
Member of the Executive Board
Headquarters & legal address
7 ALLEE DU MOULIN BERGER
BATIMENT 7
ECULLY 69130
FR
BATIMENT 7
ECULLY 69130
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY |
|---|---|
| 2025‑12 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | |
Net income | |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | |
Price | |
Market cap | |
EV | |
EBITDA | |
EV/EBITDA | |
Interest | |
Interest/NOPBT | |